Herpes simplex virus 2
Herpes simplex virus 2 has been studied in 3 papers since 2023: 2 observational studies in people, 1 review; 1 in the past year. The newest paper, Sep 24, 2026: “Alphaherpesviruses and neurodegeneration: from molecular mechanisms of persistence to clinical preventive strategies”.
3 papers study it2 findingsUpdated
See all 3 papers on herpes simplex virus 2
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“CMV and HSV-2 serologies were associated with impaired executive function”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Institute of Neurological Disorders and Stroke and 2 more
- Humans2
What did studies of herpes simplex virus 2 find?
1Studies of herpes simplex virus 2 measured one outcome, executive function.
Executive function
downin humans1
1 study
Executive function
downin humans1
Herpes simplex virus 2 is linked with worse executive function in humans (confounder-adjusted mixed linear regression).
“CMV and HSV-2 serologies were associated with impaired executive function”
Humansconfounder-adjusted mixed linear regression
Alzheimer's & dementia : the journal of the Alzheimer's Association
What is herpes simplex virus 2 linked with?
1Studies link herpes simplex virus 2 with whole-brain cortical thickness.
Whole-brain cortical thickness
downin humans1
1 study
Whole-brain cortical thickness
downin humans1
Herpes simplex virus 2 is associated with whole-brain cortical thickness in humans.
“increased serologic titers of herpes simplex virus 2 were associated with reduced whole-brain cortical thickness”
Humansbrainn = 455
Journal of the neurological sciences